<?xml version="1.0" encoding="UTF-8" ?>
< oai_dc:dc schemaLocation =" http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd " >
< dc:title > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ dc:title >
< dc:creator > Guerra Sánchez, Antonio </ dc:creator >
< dc:creator > Cano Calvo, Paula </ dc:creator >
< dc:creator > Rabionet Díaz, Marc </ dc:creator >
< dc:creator > Puig i Miquel, Teresa </ dc:creator >
< dc:creator > Ciurana, Quim de </ dc:creator >
< dc:contributor > Ministerio de Economía y Competitividad (Espanya) </ dc:contributor >
< dc:subject > Impressió 3D </ dc:subject >
< dc:subject > Three-dimensional printing </ dc:subject >
< dc:subject > Polímers en medicina </ dc:subject >
< dc:subject > Polymers in medicine </ dc:subject >
< dc:subject > Pròtesis de Stent -- Fabricació </ dc:subject >
< dc:subject > Stents (Surgery) -- Construction </ dc:subject >
< dc:description > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ dc:description >
< dc:description > This research was funded by the Ministry of Economy and Competitiveness (MINECO), Spain, (grant number DPI2016-77156-R), the University of Girona (grant number MPCUdG2016/036) and the Catalan Government (grant 2017SGR00385) </ dc:description >
< dc:date > 2018-09-11 </ dc:date >
< dc:type > info:eu-repo/semantics/article </ dc:type >
< dc:type > info:eu-repo/semantics/publishedVersion </ dc:type >
< dc:type > peer-reviewed </ dc:type >
< dc:identifier > http://hdl.handle.net/10256/15801 </ dc:identifier >
< dc:identifier > 30208592 </ dc:identifier >
< dc:identifier > PMC6164695 </ dc:identifier >
< dc:relation > info:eu-repo/semantics/altIdentifier/doi/10.3390/ma11091679 </ dc:relation >
< dc:relation > info:eu-repo/semantics/altIdentifier/issn/1996-1944 </ dc:relation >
< dc:language > eng </ dc:language >
< dc:relation > MINECO/PE 2016-2020/DPI2016-77156-R </ dc:relation >
< dc:source > Materials, 2018, vol. 11, núm. 9, p. 1679 </ dc:source >
< dc:source > Articles publicats (D-EMCI) </ dc:source >
< dc:rights > Attribution 4.0 International </ dc:rights >
< dc:rights > http://creativecommons.org/licenses/by/4.0/ </ dc:rights >
< dc:rights > info:eu-repo/semantics/openAccess </ dc:rights >
< dc:format > application/pdf </ dc:format >
< dc:publisher > MDPI (Multidisciplinary Digital Publishing Institute) </ dc:publisher >
</ oai_dc:dc >
<?xml version="1.0" encoding="UTF-8" ?>
< d:DIDL schemaLocation =" urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd " >
< d:DIDLInfo >
< dcterms:created schemaLocation =" http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd " > 2018-09-12T12:41:44Z </ dcterms:created >
</ d:DIDLInfo >
< d:Item id =" hdl_10256_15801 " >
< d:Descriptor >
< d:Statement mimeType =" application/xml; charset=utf-8 " >
< dii:Identifier schemaLocation =" urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd " > urn:hdl:10256/15801 </ dii:Identifier >
</ d:Statement >
</ d:Descriptor >
< d:Descriptor >
< d:Statement mimeType =" application/xml; charset=utf-8 " >
< oai_dc:dc schemaLocation =" http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd " >
< dc:title > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ dc:title >
< dc:creator > Guerra Sánchez, Antonio </ dc:creator >
< dc:creator > Cano Calvo, Paula </ dc:creator >
< dc:creator > Rabionet Díaz, Marc </ dc:creator >
< dc:creator > Puig i Miquel, Teresa </ dc:creator >
< dc:creator > Ciurana, Quim de </ dc:creator >
< dc:contributor > Ministerio de Economía y Competitividad (Espanya) </ dc:contributor >
< dc:subject > Impressió 3D </ dc:subject >
< dc:subject > Three-dimensional printing </ dc:subject >
< dc:subject > Polímers en medicina </ dc:subject >
< dc:subject > Polymers in medicine </ dc:subject >
< dc:subject > Pròtesis de Stent -- Fabricació </ dc:subject >
< dc:subject > Stents (Surgery) -- Construction </ dc:subject >
< dc:description > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ dc:description >
< dc:date > 2018-09-12T12:41:44Z </ dc:date >
< dc:date > 2018-09-12T12:41:44Z </ dc:date >
< dc:date > 2018-09-11 </ dc:date >
< dc:type > info:eu-repo/semantics/article </ dc:type >
< dc:identifier > 1996-1944 </ dc:identifier >
< dc:identifier > http://hdl.handle.net/10256/15801 </ dc:identifier >
< dc:identifier > https://doi.org/10.3390/ma11091679 </ dc:identifier >
< dc:identifier > 029102 </ dc:identifier >
< dc:identifier > 30208592 </ dc:identifier >
< dc:identifier > PMC6164695 </ dc:identifier >
< dc:language > eng </ dc:language >
< dc:relation > Reproducció digital del document publicat a: https://doi.org/10.3390/ma11091679 </ dc:relation >
< dc:relation > Materials, 2018, vol. 11, núm. 9, p. 1679 </ dc:relation >
< dc:relation > Articles publicats (D-EMCI) </ dc:relation >
< dc:relation > MINECO/PE 2016-2020/DPI2016-77156-R </ dc:relation >
< dc:rights > http://creativecommons.org/licenses/by/4.0/ </ dc:rights >
< dc:rights > info:eu-repo/semantics/openAccess </ dc:rights >
< dc:rights > Attribution 4.0 International </ dc:rights >
< dc:publisher > MDPI (Multidisciplinary Digital Publishing Institute) </ dc:publisher >
</ oai_dc:dc >
</ d:Statement >
</ d:Descriptor >
< d:Component id =" 10256_15801_1 " >
</ d:Component >
</ d:Item >
</ d:DIDL >
<?xml version="1.0" encoding="UTF-8" ?>
< dim:dim schemaLocation =" http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd " >
< dim:field element =" contributor " mdschema =" dc " qualifier =" author " > Guerra Sánchez, Antonio </ dim:field >
< dim:field element =" contributor " mdschema =" dc " qualifier =" author " > Cano Calvo, Paula </ dim:field >
< dim:field element =" contributor " mdschema =" dc " qualifier =" author " > Rabionet Díaz, Marc </ dim:field >
< dim:field element =" contributor " mdschema =" dc " qualifier =" author " > Puig i Miquel, Teresa </ dim:field >
< dim:field element =" contributor " mdschema =" dc " qualifier =" author " > Ciurana, Quim de </ dim:field >
< dim:field element =" contributor " mdschema =" dc " qualifier =" funder " > Ministerio de Economía y Competitividad (Espanya) </ dim:field >
< dim:field element =" date " mdschema =" dc " qualifier =" accessioned " > 2018-09-12T12:41:44Z </ dim:field >
< dim:field element =" date " mdschema =" dc " qualifier =" available " > 2018-09-12T12:41:44Z </ dim:field >
< dim:field element =" date " mdschema =" dc " qualifier =" issued " > 2018-09-11 </ dim:field >
< dim:field element =" identifier " mdschema =" dc " qualifier =" issn " > 1996-1944 </ dim:field >
< dim:field element =" identifier " mdschema =" dc " qualifier =" uri " > http://hdl.handle.net/10256/15801 </ dim:field >
< dim:field element =" identifier " mdschema =" dc " qualifier =" doi " > https://doi.org/10.3390/ma11091679 </ dim:field >
< dim:field element =" identifier " mdschema =" dc " qualifier =" idgrec " > 029102 </ dim:field >
< dim:field element =" identifier " mdschema =" dc " qualifier =" PMID " > 30208592 </ dim:field >
< dim:field element =" identifier " mdschema =" dc " qualifier =" PMCID " > PMC6164695 </ dim:field >
< dim:field element =" description " mdschema =" dc " qualifier =" abstract " > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ dim:field >
< dim:field element =" description " mdschema =" dc " qualifier =" provenance " > Submitted by CLAUDIA PLANA (claudia.plana@udg.edu) on 2018-09-12T12:41:43Z No. of bitstreams: 2 license_rdf: 908 bytes, checksum: 0175ea4a2d4caec4bbcc37e300941108 (MD5) 3DPrintedPCL.pdf: 3960090 bytes, checksum: cd7f68cfea4bf0f2fc596a52047293b2 (MD5) </ dim:field >
< dim:field element =" description " mdschema =" dc " qualifier =" provenance " > Made available in DSpace on 2018-09-12T12:41:44Z (GMT). No. of bitstreams: 2 license_rdf: 908 bytes, checksum: 0175ea4a2d4caec4bbcc37e300941108 (MD5) 3DPrintedPCL.pdf: 3960090 bytes, checksum: cd7f68cfea4bf0f2fc596a52047293b2 (MD5) Previous issue date: 2018-09-11 </ dim:field >
< dim:field element =" description " mdschema =" dc " qualifier =" sponsorship " > This research was funded by the Ministry of Economy and Competitiveness (MINECO), Spain, (grant number DPI2016-77156-R), the University of Girona (grant number MPCUdG2016/036) and the Catalan Government (grant 2017SGR00385) </ dim:field >
< dim:field element =" format " mdschema =" dc " qualifier =" mimetype " > application/pdf </ dim:field >
< dim:field element =" language " mdschema =" dc " qualifier =" iso " > eng </ dim:field >
< dim:field element =" publisher " mdschema =" dc " > MDPI (Multidisciplinary Digital Publishing Institute) </ dim:field >
< dim:field element =" relation " mdschema =" dc " > MINECO/PE 2016-2020/DPI2016-77156-R </ dim:field >
< dim:field element =" relation " mdschema =" dc " qualifier =" isformatof " > Reproducció digital del document publicat a: https://doi.org/10.3390/ma11091679 </ dim:field >
< dim:field element =" relation " mdschema =" dc " qualifier =" ispartof " > Materials, 2018, vol. 11, núm. 9, p. 1679 </ dim:field >
< dim:field element =" relation " mdschema =" dc " qualifier =" ispartofseries " > Articles publicats (D-EMCI) </ dim:field >
< dim:field element =" rights " mdschema =" dc " > Attribution 4.0 International </ dim:field >
< dim:field element =" rights " mdschema =" dc " qualifier =" uri " > http://creativecommons.org/licenses/by/4.0/ </ dim:field >
< dim:field element =" rights " mdschema =" dc " qualifier =" accessRights " > info:eu-repo/semantics/openAccess </ dim:field >
< dim:field element =" subject " mdschema =" dc " > Impressió 3D </ dim:field >
< dim:field element =" subject " mdschema =" dc " > Three-dimensional printing </ dim:field >
< dim:field element =" subject " mdschema =" dc " > Polímers en medicina </ dim:field >
< dim:field element =" subject " mdschema =" dc " > Polymers in medicine </ dim:field >
< dim:field element =" subject " mdschema =" dc " > Pròtesis de Stent -- Fabricació </ dim:field >
< dim:field element =" subject " mdschema =" dc " > Stents (Surgery) -- Construction </ dim:field >
< dim:field element =" title " mdschema =" dc " > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ dim:field >
< dim:field element =" type " mdschema =" dc " > info:eu-repo/semantics/article </ dim:field >
< dim:field element =" type " mdschema =" dc " qualifier =" version " > info:eu-repo/semantics/publishedVersion </ dim:field >
< dim:field element =" type " mdschema =" dc " qualifier =" peerreviewed " > peer-reviewed </ dim:field >
</ dim:dim >
<?xml version="1.0" encoding="UTF-8" ?>
< rdf:RDF schemaLocation =" http://www.w3.org/1999/02/22-rdf-syntax-ns# http://www.europeana.eu/schemas/edm/EDM.xsd " >
< edm:ProvidedCHO about =" https://catalonica.bnc.cat/catalonicahub/lod/oai:dugi-doc.udg.edu:10256_--_15801#ent0 " >
< dc:contributor > Ministerio de Economía y Competitividad (Espanya) </ dc:contributor >
< dc:creator > Guerra Sánchez, Antonio </ dc:creator >
< dc:creator > Cano Calvo, Paula </ dc:creator >
< dc:creator > Rabionet Díaz, Marc </ dc:creator >
< dc:creator > Puig i Miquel, Teresa </ dc:creator >
< dc:creator > Ciurana, Quim de </ dc:creator >
< dc:date > 2018-09-11 </ dc:date >
< dc:description > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ dc:description >
< dc:description > This research was funded by the Ministry of Economy and Competitiveness (MINECO), Spain, (grant number DPI2016-77156-R), the University of Girona (grant number MPCUdG2016/036) and the Catalan Government (grant 2017SGR00385) </ dc:description >
< dc:identifier > http://hdl.handle.net/10256/15801 </ dc:identifier >
< dc:identifier > 30208592 </ dc:identifier >
< dc:identifier > PMC6164695 </ dc:identifier >
< dc:language > eng </ dc:language >
< dc:publisher > MDPI (Multidisciplinary Digital Publishing Institute) </ dc:publisher >
< dc:relation > info:eu-repo/semantics/altIdentifier/doi/10.3390/ma11091679 </ dc:relation >
< dc:relation > info:eu-repo/semantics/altIdentifier/issn/1996-1944 </ dc:relation >
< dc:relation > MINECO/PE 2016-2020/DPI2016-77156-R </ dc:relation >
< dc:rights > Attribution 4.0 International </ dc:rights >
< dc:rights > http://creativecommons.org/licenses/by/4.0/ </ dc:rights >
< dc:rights > info:eu-repo/semantics/openAccess </ dc:rights >
< dc:source > Materials, 2018, vol. 11, núm. 9, p. 1679 </ dc:source >
< dc:source > Articles publicats (D-EMCI) </ dc:source >
< dc:subject > Impressió 3D </ dc:subject >
< dc:subject > Three-dimensional printing </ dc:subject >
< dc:subject > Polímers en medicina </ dc:subject >
< dc:subject > Polymers in medicine </ dc:subject >
< dc:subject > Pròtesis de Stent -- Fabricació </ dc:subject >
< dc:subject > Stents (Surgery) -- Construction </ dc:subject >
< dc:title > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ dc:title >
< dc:type > info:eu-repo/semantics/article </ dc:type >
< dc:type > info:eu-repo/semantics/publishedVersion </ dc:type >
< dc:type > peer-reviewed </ dc:type >
< edm:type > TEXT </ edm:type >
</ edm:ProvidedCHO >
< ore:Aggregation about =" https://catalonica.bnc.cat/catalonicahub/lod/oai:dugi-doc.udg.edu:10256_--_15801#ent1 " >
< edm:dataProvider > DUGiDocs. Recerca </ edm:dataProvider >
< edm:provider > Catalònica </ edm:provider >
</ ore:Aggregation >
</ rdf:RDF >
<?xml version="1.0" encoding="UTF-8" ?>
< thesis schemaLocation =" http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd " >
< title > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ title >
< creator > Guerra Sánchez, Antonio </ creator >
< creator > Cano Calvo, Paula </ creator >
< creator > Rabionet Díaz, Marc </ creator >
< creator > Puig i Miquel, Teresa </ creator >
< creator > Ciurana, Quim de </ creator >
< contributor > Ministerio de Economía y Competitividad (Espanya) </ contributor >
< subject > Impressió 3D </ subject >
< subject > Three-dimensional printing </ subject >
< subject > Polímers en medicina </ subject >
< subject > Polymers in medicine </ subject >
< subject > Pròtesis de Stent -- Fabricació </ subject >
< subject > Stents (Surgery) -- Construction </ subject >
< description > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ description >
< date > 2018-09-12 </ date >
< date > 2018-09-12 </ date >
< date > 2018-09-11 </ date >
< type > info:eu-repo/semantics/article </ type >
< identifier > 1996-1944 </ identifier >
< identifier > http://hdl.handle.net/10256/15801 </ identifier >
< identifier > https://doi.org/10.3390/ma11091679 </ identifier >
< identifier > 029102 </ identifier >
< identifier > 30208592 </ identifier >
< identifier > PMC6164695 </ identifier >
< language > eng </ language >
< relation > Reproducció digital del document publicat a: https://doi.org/10.3390/ma11091679 </ relation >
< relation > Materials, 2018, vol. 11, núm. 9, p. 1679 </ relation >
< relation > Articles publicats (D-EMCI) </ relation >
< relation > MINECO/PE 2016-2020/DPI2016-77156-R </ relation >
< rights > http://creativecommons.org/licenses/by/4.0/ </ rights >
< rights > info:eu-repo/semantics/openAccess </ rights >
< rights > Attribution 4.0 International </ rights >
< publisher > MDPI (Multidisciplinary Digital Publishing Institute) </ publisher >
</ thesis >
<?xml version="1.0" encoding="UTF-8" ?>
< record schemaLocation =" http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd " >
< leader > 00925njm 22002777a 4500 </ leader >
< datafield ind1 =" " ind2 =" " tag =" 042 " >
< subfield code =" a " > dc </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 720 " >
< subfield code =" a " > Guerra Sánchez, Antonio </ subfield >
< subfield code =" e " > author </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 720 " >
< subfield code =" a " > Cano Calvo, Paula </ subfield >
< subfield code =" e " > author </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 720 " >
< subfield code =" a " > Rabionet Díaz, Marc </ subfield >
< subfield code =" e " > author </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 720 " >
< subfield code =" a " > Puig i Miquel, Teresa </ subfield >
< subfield code =" e " > author </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 720 " >
< subfield code =" a " > Ciurana, Quim de </ subfield >
< subfield code =" e " > author </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 260 " >
< subfield code =" c " > 2018-09-11 </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 520 " >
< subfield code =" a " > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ subfield >
</ datafield >
< datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
< subfield code =" a " > 1996-1944 </ subfield >
</ datafield >
< datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
< subfield code =" a " > http://hdl.handle.net/10256/15801 </ subfield >
</ datafield >
< datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
< subfield code =" a " > https://doi.org/10.3390/ma11091679 </ subfield >
</ datafield >
< datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
< subfield code =" a " > 029102 </ subfield >
</ datafield >
< datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
< subfield code =" a " > 30208592 </ subfield >
</ datafield >
< datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
< subfield code =" a " > PMC6164695 </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 653 " >
< subfield code =" a " > Impressió 3D </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 653 " >
< subfield code =" a " > Three-dimensional printing </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 653 " >
< subfield code =" a " > Polímers en medicina </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 653 " >
< subfield code =" a " > Polymers in medicine </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 653 " >
< subfield code =" a " > Pròtesis de Stent -- Fabricació </ subfield >
</ datafield >
< datafield ind1 =" " ind2 =" " tag =" 653 " >
< subfield code =" a " > Stents (Surgery) -- Construction </ subfield >
</ datafield >
< datafield ind1 =" 0 " ind2 =" 0 " tag =" 245 " >
< subfield code =" a " > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ subfield >
</ datafield >
</ record >
<?xml version="1.0" encoding="UTF-8" ?>
< mets ID =" DSpace_ITEM_10256-15801 " OBJID =" hdl:10256/15801 " PROFILE =" DSpace METS SIP Profile 1.0 " TYPE =" DSpace ITEM " schemaLocation =" http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd " >
< metsHdr CREATEDATE =" 2025-06-03T05:00:32Z " >
< agent ROLE =" CUSTODIAN " TYPE =" ORGANIZATION " >
< name > DUGiDocs </ name >
</ agent >
</ metsHdr >
< dmdSec ID =" DMD_10256_15801 " >
< mdWrap MDTYPE =" MODS " >
< xmlData schemaLocation =" http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd " >
< mods:mods schemaLocation =" http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd " >
< mods:name >
< mods:role >
< mods:roleTerm type =" text " > author </ mods:roleTerm >
</ mods:role >
< mods:namePart > Guerra Sánchez, Antonio </ mods:namePart >
</ mods:name >
< mods:name >
< mods:role >
< mods:roleTerm type =" text " > author </ mods:roleTerm >
</ mods:role >
< mods:namePart > Cano Calvo, Paula </ mods:namePart >
</ mods:name >
< mods:name >
< mods:role >
< mods:roleTerm type =" text " > author </ mods:roleTerm >
</ mods:role >
< mods:namePart > Rabionet Díaz, Marc </ mods:namePart >
</ mods:name >
< mods:name >
< mods:role >
< mods:roleTerm type =" text " > author </ mods:roleTerm >
</ mods:role >
< mods:namePart > Puig i Miquel, Teresa </ mods:namePart >
</ mods:name >
< mods:name >
< mods:role >
< mods:roleTerm type =" text " > author </ mods:roleTerm >
</ mods:role >
< mods:namePart > Ciurana, Quim de </ mods:namePart >
</ mods:name >
< mods:name >
< mods:role >
< mods:roleTerm type =" text " > funder </ mods:roleTerm >
</ mods:role >
< mods:namePart > Ministerio de Economía y Competitividad (Espanya) </ mods:namePart >
</ mods:name >
< mods:extension >
< mods:dateAccessioned encoding =" iso8601 " > 2018-09-12T12:41:44Z </ mods:dateAccessioned >
</ mods:extension >
< mods:extension >
< mods:dateAvailable encoding =" iso8601 " > 2018-09-12T12:41:44Z </ mods:dateAvailable >
</ mods:extension >
< mods:originInfo >
< mods:dateIssued encoding =" iso8601 " > 2018-09-11 </ mods:dateIssued >
</ mods:originInfo >
< mods:identifier type =" issn " > 1996-1944 </ mods:identifier >
< mods:identifier type =" uri " > http://hdl.handle.net/10256/15801 </ mods:identifier >
< mods:identifier type =" doi " > https://doi.org/10.3390/ma11091679 </ mods:identifier >
< mods:identifier type =" idgrec " > 029102 </ mods:identifier >
< mods:identifier type =" PMID " > 30208592 </ mods:identifier >
< mods:identifier type =" PMCID " > PMC6164695 </ mods:identifier >
< mods:abstract > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ mods:abstract >
< mods:language >
< mods:languageTerm authority =" rfc3066 " > eng </ mods:languageTerm >
</ mods:language >
< mods:accessCondition type =" useAndReproduction " > Attribution 4.0 International </ mods:accessCondition >
< mods:subject >
< mods:topic > Impressió 3D </ mods:topic >
</ mods:subject >
< mods:subject >
< mods:topic > Three-dimensional printing </ mods:topic >
</ mods:subject >
< mods:subject >
< mods:topic > Polímers en medicina </ mods:topic >
</ mods:subject >
< mods:subject >
< mods:topic > Polymers in medicine </ mods:topic >
</ mods:subject >
< mods:subject >
< mods:topic > Pròtesis de Stent -- Fabricació </ mods:topic >
</ mods:subject >
< mods:subject >
< mods:topic > Stents (Surgery) -- Construction </ mods:topic >
</ mods:subject >
< mods:titleInfo >
< mods:title > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ mods:title >
</ mods:titleInfo >
< mods:genre > info:eu-repo/semantics/article </ mods:genre >
</ mods:mods >
</ xmlData >
</ mdWrap >
</ dmdSec >
< amdSec ID =" TMD_10256_15801 " >
< rightsMD ID =" RIG_10256_15801 " >
< mdWrap MDTYPE =" OTHER " MIMETYPE =" text/plain " OTHERMDTYPE =" DSpaceDepositLicense " >
< binData > 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 </ binData >
</ mdWrap >
</ rightsMD >
</ amdSec >
< amdSec ID =" FO_10256_15801_1 " >
< techMD ID =" TECH_O_10256_15801_1 " >
< mdWrap MDTYPE =" PREMIS " >
< xmlData schemaLocation =" http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd " >
< premis:premis >
< premis:object >
< premis:objectIdentifier >
< premis:objectIdentifierType > URL </ premis:objectIdentifierType >
< premis:objectIdentifierValue > https://dugi-doc.udg.edu/bitstream/10256/15801/1/3DPrintedPCL.pdf </ premis:objectIdentifierValue >
</ premis:objectIdentifier >
< premis:objectCategory > File </ premis:objectCategory >
< premis:objectCharacteristics >
< premis:fixity >
< premis:messageDigestAlgorithm > MD5 </ premis:messageDigestAlgorithm >
< premis:messageDigest > cd7f68cfea4bf0f2fc596a52047293b2 </ premis:messageDigest >
</ premis:fixity >
< premis:size > 3960090 </ premis:size >
< premis:format >
< premis:formatDesignation >
< premis:formatName > application/pdf </ premis:formatName >
</ premis:formatDesignation >
</ premis:format >
</ premis:objectCharacteristics >
< premis:originalName > 3DPrintedPCL.pdf </ premis:originalName >
</ premis:object >
</ premis:premis >
</ xmlData >
</ mdWrap >
</ techMD >
</ amdSec >
< fileSec >
< fileGrp USE =" ORIGINAL " >
< file ADMID =" FO_10256_15801_1 " CHECKSUM =" cd7f68cfea4bf0f2fc596a52047293b2 " CHECKSUMTYPE =" MD5 " GROUPID =" GROUP_BITSTREAM_10256_15801_1 " ID =" BITSTREAM_ORIGINAL_10256_15801_1 " MIMETYPE =" application/pdf " SEQ =" 1 " SIZE =" 3960090 " >
</ file >
</ fileGrp >
</ fileSec >
< structMap LABEL =" DSpace Object " TYPE =" LOGICAL " >
< div ADMID =" DMD_10256_15801 " TYPE =" DSpace Object Contents " >
< div TYPE =" DSpace BITSTREAM " >
</ div >
</ div >
</ structMap >
</ mets >
<?xml version="1.0" encoding="UTF-8" ?>
< mods:mods schemaLocation =" http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd " >
< mods:name >
< mods:namePart > Guerra Sánchez, Antonio </ mods:namePart >
</ mods:name >
< mods:name >
< mods:namePart > Cano Calvo, Paula </ mods:namePart >
</ mods:name >
< mods:name >
< mods:namePart > Rabionet Díaz, Marc </ mods:namePart >
</ mods:name >
< mods:name >
< mods:namePart > Puig i Miquel, Teresa </ mods:namePart >
</ mods:name >
< mods:name >
< mods:namePart > Ciurana, Quim de </ mods:namePart >
</ mods:name >
< mods:extension >
< mods:dateAvailable encoding =" iso8601 " > 2018-09-12T12:41:44Z </ mods:dateAvailable >
</ mods:extension >
< mods:extension >
< mods:dateAccessioned encoding =" iso8601 " > 2018-09-12T12:41:44Z </ mods:dateAccessioned >
</ mods:extension >
< mods:originInfo >
< mods:dateIssued encoding =" iso8601 " > 2018-09-11 </ mods:dateIssued >
</ mods:originInfo >
< mods:identifier type =" issn " > 1996-1944 </ mods:identifier >
< mods:identifier type =" uri " > http://hdl.handle.net/10256/15801 </ mods:identifier >
< mods:identifier type =" doi " > https://doi.org/10.3390/ma11091679 </ mods:identifier >
< mods:identifier type =" idgrec " > 029102 </ mods:identifier >
< mods:identifier type =" PMID " > 30208592 </ mods:identifier >
< mods:identifier type =" PMCID " > PMC6164695 </ mods:identifier >
< mods:abstract > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ mods:abstract >
< mods:language >
< mods:languageTerm > eng </ mods:languageTerm >
</ mods:language >
< mods:accessCondition type =" useAndReproduction " > http://creativecommons.org/licenses/by/4.0/ </ mods:accessCondition >
< mods:accessCondition type =" useAndReproduction " > info:eu-repo/semantics/openAccess </ mods:accessCondition >
< mods:accessCondition type =" useAndReproduction " > Attribution 4.0 International </ mods:accessCondition >
< mods:subject >
< mods:topic > Impressió 3D </ mods:topic >
</ mods:subject >
< mods:subject >
< mods:topic > Three-dimensional printing </ mods:topic >
</ mods:subject >
< mods:subject >
< mods:topic > Polímers en medicina </ mods:topic >
</ mods:subject >
< mods:subject >
< mods:topic > Polymers in medicine </ mods:topic >
</ mods:subject >
< mods:subject >
< mods:topic > Pròtesis de Stent -- Fabricació </ mods:topic >
</ mods:subject >
< mods:subject >
< mods:topic > Stents (Surgery) -- Construction </ mods:topic >
</ mods:subject >
< mods:titleInfo >
< mods:title > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ mods:title >
</ mods:titleInfo >
< mods:genre > info:eu-repo/semantics/article </ mods:genre >
</ mods:mods >
<?xml version="1.0" encoding="UTF-8" ?>
< datacite:resource schemaLocation =" http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4-2/metadata.xsd " >
< datacite:identifier identifierType =" Handle " > http://hdl.handle.net/10256/15801 </ datacite:identifier >
< datacite:titles >
< datacite:title > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ datacite:title >
</ datacite:titles >
< datacite:creators >
< datacite:creator >
< datacite:creatorName > Guerra Sánchez, Antonio </ datacite:creatorName >
< datacite:nameIdentifier nameIdentifierScheme =" ORCID " schemeURI =" http://orcid.org/ " > 0000-0003-2883-2530 </ datacite:nameIdentifier >
</ datacite:creator >
< datacite:creator >
< datacite:creatorName > Cano Calvo, Paula </ datacite:creatorName >
</ datacite:creator >
< datacite:creator >
< datacite:creatorName > Rabionet Díaz, Marc </ datacite:creatorName >
< datacite:nameIdentifier nameIdentifierScheme =" ORCID " schemeURI =" http://orcid.org/ " > 0000-0003-1257-9286 </ datacite:nameIdentifier >
</ datacite:creator >
< datacite:creator >
< datacite:creatorName > Puig i Miquel, Teresa </ datacite:creatorName >
< datacite:nameIdentifier nameIdentifierScheme =" ORCID " schemeURI =" http://orcid.org/ " > 0000-0003-2715-7043 </ datacite:nameIdentifier >
</ datacite:creator >
< datacite:creator >
< datacite:creatorName > Ciurana, Quim de </ datacite:creatorName >
< datacite:nameIdentifier nameIdentifierScheme =" ORCID " schemeURI =" http://orcid.org/ " > 0000-0002-6574-5551 </ datacite:nameIdentifier >
</ datacite:creator >
</ datacite:creators >
< datacite:subjects >
< datacite:subject > Impressió 3D </ datacite:subject >
< datacite:subject > Three-dimensional printing </ datacite:subject >
< datacite:subject > Polímers en medicina </ datacite:subject >
< datacite:subject > Polymers in medicine </ datacite:subject >
< datacite:subject > Pròtesis de Stent -- Fabricació </ datacite:subject >
< datacite:subject > Stents (Surgery) -- Construction </ datacite:subject >
</ datacite:subjects >
< datacite:descriptions >
< datacite:description descriptionType =" Abstract " > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ datacite:description >
</ datacite:descriptions >
< datacite:dates >
< datacite:date dateType =" Issued " > 2018-09-11 </ datacite:date >
</ datacite:dates >
< datacite:publicationYear > 2018 </ datacite:publicationYear >
< datacite:languages >
< datacite:language > eng </ datacite:language >
</ datacite:languages >
< datacite:relatedIdentifiers >
< datacite:relatedIdentifier relatedIdentifierType =" URL " relationType =" IsSupplementTo " > 1996-1944 </ datacite:relatedIdentifier >
< datacite:relatedIdentifier relatedIdentifierType =" DOI " relationType =" IsSupplementTo " > https://doi.org/10.3390/ma11091679 </ datacite:relatedIdentifier >
< datacite:relatedIdentifier relatedIdentifierType =" URL " relationType =" IsSupplementTo " > 029102 </ datacite:relatedIdentifier >
< datacite:relatedIdentifier relatedIdentifierType =" URL " relationType =" IsSupplementTo " > 30208592 </ datacite:relatedIdentifier >
< datacite:relatedIdentifier relatedIdentifierType =" URL " relationType =" IsSupplementTo " > PMC6164695 </ datacite:relatedIdentifier >
</ datacite:relatedIdentifiers >
< datacite:rightsList >
< datacite:rights > Attribution 4.0 International </ datacite:rights >
< datacite:rights rightsURI =" http://creativecommons.org/licenses/by/4.0/ " > http://creativecommons.org/licenses/by/4.0/ </ datacite:rights >
< datacite:rights rightsURI =" info:eu-repo/semantics/openAccess " > info:eu-repo/semantics/openAccess </ datacite:rights >
</ datacite:rightsList >
< datacite:formats >
< datacite:format > application/pdf </ datacite:format >
</ datacite:formats >
< datacite:publisher > MDPI (Multidisciplinary Digital Publishing Institute) </ datacite:publisher >
</ datacite:resource >
<?xml version="1.0" encoding="UTF-8" ?>
< atom:entry schemaLocation =" http://www.w3.org/2005/Atom http://www.kbcafe.com/rss/atom.xsd.xml " >
< atom:id > http://hdl.handle.net/10256/15801/ore.xml </ atom:id >
< atom:published > 2018-09-12T12:41:44Z </ atom:published >
< atom:updated > 2018-09-12T12:41:44Z </ atom:updated >
< atom:source >
< atom:generator > DUGiDocs </ atom:generator >
</ atom:source >
< atom:title > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ atom:title >
< atom:author >
< atom:name > Guerra Sánchez, Antonio </ atom:name >
</ atom:author >
< atom:author >
< atom:name > Cano Calvo, Paula </ atom:name >
</ atom:author >
< atom:author >
< atom:name > Rabionet Díaz, Marc </ atom:name >
</ atom:author >
< atom:author >
< atom:name > Puig i Miquel, Teresa </ atom:name >
</ atom:author >
< atom:author >
< atom:name > Ciurana, Quim de </ atom:name >
</ atom:author >
< oreatom:triples >
< rdf:Description about =" http://hdl.handle.net/10256/15801/ore.xml#atom " >
< dcterms:modified > 2018-09-12T12:41:44Z </ dcterms:modified >
</ rdf:Description >
< rdf:Description about =" https://dugi-doc.udg.edu/bitstream/10256/15801/3/license.txt " >
< dcterms:description > LICENSE </ dcterms:description >
</ rdf:Description >
< rdf:Description about =" https://dugi-doc.udg.edu/bitstream/10256/15801/2/license_rdf " >
< dcterms:description > CC-LICENSE </ dcterms:description >
</ rdf:Description >
< rdf:Description about =" https://dugi-doc.udg.edu/bitstream/10256/15801/1/3DPrintedPCL.pdf " >
< dcterms:description > ORIGINAL </ dcterms:description >
</ rdf:Description >
</ oreatom:triples >
</ atom:entry >
<?xml version="1.0" encoding="UTF-8" ?>
< qdc:qualifieddc schemaLocation =" http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd " >
< dc:title > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ dc:title >
< dc:creator > Guerra Sánchez, Antonio </ dc:creator >
< dc:creator > Cano Calvo, Paula </ dc:creator >
< dc:creator > Rabionet Díaz, Marc </ dc:creator >
< dc:creator > Puig i Miquel, Teresa </ dc:creator >
< dc:creator > Ciurana, Quim de </ dc:creator >
< dc:contributor > Ministerio de Economía y Competitividad (Espanya) </ dc:contributor >
< dc:subject > Impressió 3D </ dc:subject >
< dc:subject > Three-dimensional printing </ dc:subject >
< dc:subject > Polímers en medicina </ dc:subject >
< dc:subject > Polymers in medicine </ dc:subject >
< dc:subject > Pròtesis de Stent -- Fabricació </ dc:subject >
< dc:subject > Stents (Surgery) -- Construction </ dc:subject >
< dcterms:abstract > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ dcterms:abstract >
< dcterms:issued > 2018-09-11 </ dcterms:issued >
< dc:type > info:eu-repo/semantics/article </ dc:type >
< dc:identifier > 1996-1944 </ dc:identifier >
< dc:identifier > http://hdl.handle.net/10256/15801 </ dc:identifier >
< dc:identifier > https://doi.org/10.3390/ma11091679 </ dc:identifier >
< dc:identifier > 029102 </ dc:identifier >
< dc:identifier > 30208592 </ dc:identifier >
< dc:identifier > PMC6164695 </ dc:identifier >
< dc:language > eng </ dc:language >
< dc:relation > Reproducció digital del document publicat a: https://doi.org/10.3390/ma11091679 </ dc:relation >
< dc:relation > Materials, 2018, vol. 11, núm. 9, p. 1679 </ dc:relation >
< dc:relation > Articles publicats (D-EMCI) </ dc:relation >
< dc:relation > MINECO/PE 2016-2020/DPI2016-77156-R </ dc:relation >
< dc:rights > http://creativecommons.org/licenses/by/4.0/ </ dc:rights >
< dc:rights > info:eu-repo/semantics/openAccess </ dc:rights >
< dc:rights > Attribution 4.0 International </ dc:rights >
< dc:publisher > MDPI (Multidisciplinary Digital Publishing Institute) </ dc:publisher >
</ qdc:qualifieddc >
<?xml version="1.0" encoding="UTF-8" ?>
< rdf:RDF schemaLocation =" http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd " >
< ow:Publication about =" oai:dugi-doc.udg.edu:10256/15801 " >
< dc:title > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ dc:title >
< dc:creator > Guerra Sánchez, Antonio </ dc:creator >
< dc:creator > Cano Calvo, Paula </ dc:creator >
< dc:creator > Rabionet Díaz, Marc </ dc:creator >
< dc:creator > Puig i Miquel, Teresa </ dc:creator >
< dc:creator > Ciurana, Quim de </ dc:creator >
< dc:contributor > Ministerio de Economía y Competitividad (Espanya) </ dc:contributor >
< dc:subject > Impressió 3D </ dc:subject >
< dc:subject > Three-dimensional printing </ dc:subject >
< dc:subject > Polímers en medicina </ dc:subject >
< dc:subject > Polymers in medicine </ dc:subject >
< dc:subject > Pròtesis de Stent -- Fabricació </ dc:subject >
< dc:subject > Stents (Surgery) -- Construction </ dc:subject >
< dc:description > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ dc:description >
< dc:date > 2018-09-12T12:41:44Z </ dc:date >
< dc:date > 2018-09-12T12:41:44Z </ dc:date >
< dc:date > 2018-09-11 </ dc:date >
< dc:type > info:eu-repo/semantics/article </ dc:type >
< dc:identifier > 1996-1944 </ dc:identifier >
< dc:identifier > http://hdl.handle.net/10256/15801 </ dc:identifier >
< dc:identifier > https://doi.org/10.3390/ma11091679 </ dc:identifier >
< dc:identifier > 029102 </ dc:identifier >
< dc:identifier > 30208592 </ dc:identifier >
< dc:identifier > PMC6164695 </ dc:identifier >
< dc:language > eng </ dc:language >
< dc:relation > Reproducció digital del document publicat a: https://doi.org/10.3390/ma11091679 </ dc:relation >
< dc:relation > Materials, 2018, vol. 11, núm. 9, p. 1679 </ dc:relation >
< dc:relation > Articles publicats (D-EMCI) </ dc:relation >
< dc:relation > MINECO/PE 2016-2020/DPI2016-77156-R </ dc:relation >
< dc:rights > http://creativecommons.org/licenses/by/4.0/ </ dc:rights >
< dc:rights > info:eu-repo/semantics/openAccess </ dc:rights >
< dc:rights > Attribution 4.0 International </ dc:rights >
< dc:publisher > MDPI (Multidisciplinary Digital Publishing Institute) </ dc:publisher >
</ ow:Publication >
</ rdf:RDF >
<?xml version="1.0" encoding="UTF-8" ?>
< metadata schemaLocation =" http://www.lyncode.com/xoai http://www.lyncode.com/xsd/xoai.xsd " >
< element name =" dc " >
< element name =" contributor " >
< element name =" author " >
< element name =" none " >
< field name =" value " > Guerra Sánchez, Antonio </ field >
< field name =" value " > Cano Calvo, Paula </ field >
< field name =" value " > Rabionet Díaz, Marc </ field >
< field name =" value " > Puig i Miquel, Teresa </ field >
< field name =" value " > Ciurana, Quim de </ field >
</ element >
</ element >
< element name =" funder " >
< element name =" none " >
< field name =" value " > Ministerio de Economía y Competitividad (Espanya) </ field >
</ element >
</ element >
</ element >
< element name =" date " >
< element name =" accessioned " >
< element name =" none " >
< field name =" value " > 2018-09-12T12:41:44Z </ field >
</ element >
</ element >
< element name =" available " >
< element name =" none " >
< field name =" value " > 2018-09-12T12:41:44Z </ field >
</ element >
</ element >
< element name =" issued " >
< element name =" none " >
< field name =" value " > 2018-09-11 </ field >
</ element >
</ element >
</ element >
< element name =" identifier " >
< element name =" issn " >
< element name =" none " >
< field name =" value " > 1996-1944 </ field >
</ element >
</ element >
< element name =" uri " >
< element name =" none " >
< field name =" value " > http://hdl.handle.net/10256/15801 </ field >
</ element >
</ element >
< element name =" doi " >
< element name =" none " >
< field name =" value " > https://doi.org/10.3390/ma11091679 </ field >
</ element >
</ element >
< element name =" idgrec " >
< element name =" none " >
< field name =" value " > 029102 </ field >
</ element >
</ element >
< element name =" PMID " >
< element name =" none " >
< field name =" value " > 30208592 </ field >
</ element >
</ element >
< element name =" PMCID " >
< element name =" none " >
< field name =" value " > PMC6164695 </ field >
</ element >
</ element >
</ element >
< element name =" description " >
< element name =" abstract " >
< element name =" none " >
< field name =" value " > Biodegradable stents (BRS) offer enormous potential but first they must meet five specific requirements: (i) their manufacturing process must be precise; (ii) degradation should have minimal toxicity; (iii) the rate of degradation should match the recovery rate of vascular tissue; (iv) ideally, they should induce rapid endothelialization to restore the functions of vascular tissue, but at the same time reduce the risk of restenosis; and (v) their mechanical behavior should comply with medical requirements, namely, the flexibility required to facilitate placement but also sufficient radial rigidity to support the vessel. Although the first three requirements have been comprehensively studied, the last two have been overlooked. One possible way of addressing these issues would be to fabricate composite stents using materials that have different mechanical, biological, or medical properties, for instance, Polylactide Acid (PLA) or Polycaprolactone (PCL). However, fashioning such stents using the traditional stent manufacturing process known as laser cutting would be impossible. Our work, therefore, aims to produce PCL/PLA composite stents using a novel 3D tubular printer based on Fused Deposition Modelling (FDM). The cell geometry (shape and area) and the materials (PCL and PLA) of the stents were analyzed and correlated with 3T3 cell proliferation, degradation rates, dynamic mechanical and radial expansion tests to determine the best parameters for a stent that will satisfy the five strict BRS requirements. Results proved that the 3D-printing process was highly suitable for producing composite stents (approximately 85–95% accuracy). Both PCL and PLA demonstrated their biocompatibility with PCL stents presenting an average cell proliferation of 12.46% and PLA 8.28% after only 3 days. Furthermore, the PCL/PLA composite stents demonstrated their potential in degradation, dynamic mechanical and expansion tests. Moreover, and regardless of the order of the layers, the composite stents showed (virtually) medium levels of degradation rates and mechanical modulus. Radially, they exhibited the virtues of PCL in the expansion step (elasticity) and those of PLA in the recoil step (rigidity). Results have clearly demonstrated that composite PCL/PLA stents are a highly promising solution to fulfilling the rigorous BRS requirements </ field >
</ element >
</ element >
< element name =" provenance " >
< element name =" none " >
< field name =" value " > Submitted by CLAUDIA PLANA (claudia.plana@udg.edu) on 2018-09-12T12:41:43Z No. of bitstreams: 2 license_rdf: 908 bytes, checksum: 0175ea4a2d4caec4bbcc37e300941108 (MD5) 3DPrintedPCL.pdf: 3960090 bytes, checksum: cd7f68cfea4bf0f2fc596a52047293b2 (MD5) </ field >
< field name =" value " > Made available in DSpace on 2018-09-12T12:41:44Z (GMT). No. of bitstreams: 2 license_rdf: 908 bytes, checksum: 0175ea4a2d4caec4bbcc37e300941108 (MD5) 3DPrintedPCL.pdf: 3960090 bytes, checksum: cd7f68cfea4bf0f2fc596a52047293b2 (MD5) Previous issue date: 2018-09-11 </ field >
</ element >
</ element >
< element name =" sponsorship " >
< element name =" none " >
< field name =" value " > This research was funded by the Ministry of Economy and Competitiveness (MINECO), Spain, (grant number DPI2016-77156-R), the University of Girona (grant number MPCUdG2016/036) and the Catalan Government (grant 2017SGR00385) </ field >
</ element >
</ element >
</ element >
< element name =" format " >
< element name =" mimetype " >
< element name =" none " >
< field name =" value " > application/pdf </ field >
</ element >
</ element >
</ element >
< element name =" language " >
< element name =" iso " >
< element name =" none " >
< field name =" value " > eng </ field >
</ element >
</ element >
</ element >
< element name =" publisher " >
< element name =" none " >
< field name =" value " > MDPI (Multidisciplinary Digital Publishing Institute) </ field >
</ element >
</ element >
< element name =" relation " >
< element name =" none " >
< field name =" value " > MINECO/PE 2016-2020/DPI2016-77156-R </ field >
</ element >
< element name =" isformatof " >
< element name =" none " >
< field name =" value " > Reproducció digital del document publicat a: https://doi.org/10.3390/ma11091679 </ field >
</ element >
</ element >
< element name =" ispartof " >
< element name =" none " >
< field name =" value " > Materials, 2018, vol. 11, núm. 9, p. 1679 </ field >
</ element >
</ element >
< element name =" ispartofseries " >
< element name =" none " >
< field name =" value " > Articles publicats (D-EMCI) </ field >
</ element >
</ element >
</ element >
< element name =" rights " >
< element name =" none " >
< field name =" value " > Attribution 4.0 International </ field >
</ element >
< element name =" uri " >
< element name =" none " >
< field name =" value " > http://creativecommons.org/licenses/by/4.0/ </ field >
</ element >
</ element >
< element name =" accessRights " >
< element name =" none " >
< field name =" value " > info:eu-repo/semantics/openAccess </ field >
</ element >
</ element >
</ element >
< element name =" subject " >
< element name =" none " >
< field name =" value " > Impressió 3D </ field >
< field name =" value " > Three-dimensional printing </ field >
< field name =" value " > Polímers en medicina </ field >
< field name =" value " > Polymers in medicine </ field >
< field name =" value " > Pròtesis de Stent -- Fabricació </ field >
< field name =" value " > Stents (Surgery) -- Construction </ field >
</ element >
</ element >
< element name =" title " >
< element name =" none " >
< field name =" value " > 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems </ field >
</ element >
</ element >
< element name =" type " >
< element name =" none " >
< field name =" value " > info:eu-repo/semantics/article </ field >
</ element >
< element name =" version " >
< element name =" none " >
< field name =" value " > info:eu-repo/semantics/publishedVersion </ field >
</ element >
</ element >
< element name =" peerreviewed " >
< element name =" none " >
< field name =" value " > peer-reviewed </ field >
</ element >
</ element >
</ element >
</ element >
< element name =" adm " >
< element name =" sets " >
< element name =" hidden " >
< element name =" none " >
< field name =" value " > rc1 </ field >
</ element >
</ element >
</ element >
</ element >
< element name =" bundles " >
< element name =" bundle " >
< field name =" name " > LICENSE </ field >
< element name =" bitstreams " >
< element name =" bitstream " >
< field name =" name " > license.txt </ field >
< field name =" originalName " > license.txt </ field >
< field name =" format " > text/plain </ field >
< field name =" size " > 1748 </ field >
< field name =" url " > https://dugi-doc.udg.edu/bitstream/10256/15801/3/license.txt </ field >
< field name =" checksum " > 8a4605be74aa9ea9d79846c1fba20a33 </ field >
< field name =" checksumAlgorithm " > MD5 </ field >
< field name =" sid " > 3 </ field >
</ element >
</ element >
</ element >
< element name =" bundle " >
< field name =" name " > CC-LICENSE </ field >
< element name =" bitstreams " >
< element name =" bitstream " >
< field name =" name " > license_rdf </ field >
< field name =" originalName " > license_rdf </ field >
< field name =" format " > application/rdf+xml; charset=utf-8 </ field >
< field name =" size " > 908 </ field >
< field name =" url " > https://dugi-doc.udg.edu/bitstream/10256/15801/2/license_rdf </ field >
< field name =" checksum " > 0175ea4a2d4caec4bbcc37e300941108 </ field >
< field name =" checksumAlgorithm " > MD5 </ field >
< field name =" sid " > 2 </ field >
</ element >
</ element >
</ element >
< element name =" bundle " >
< field name =" name " > ORIGINAL </ field >
< element name =" bitstreams " >
< element name =" bitstream " >
< field name =" name " > 3DPrintedPCL.pdf </ field >
< field name =" originalName " > 3DPrintedPCL.pdf </ field >
< field name =" format " > application/pdf </ field >
< field name =" size " > 3960090 </ field >
< field name =" url " > https://dugi-doc.udg.edu/bitstream/10256/15801/1/3DPrintedPCL.pdf </ field >
< field name =" checksum " > cd7f68cfea4bf0f2fc596a52047293b2 </ field >
< field name =" checksumAlgorithm " > MD5 </ field >
< field name =" sid " > 1 </ field >
</ element >
</ element >
</ element >
</ element >
< element name =" others " >
< field name =" handle " > 10256/15801 </ field >
< field name =" identifier " > oai:dugi-doc.udg.edu:10256/15801 </ field >
< field name =" lastModifyDate " > 2025-03-04 08:27:39.223 </ field >
</ element >
< element name =" repository " >
< field name =" name " > DUGiDocs </ field >
< field name =" mail " > oriol.olive@udg.edu </ field >
</ element >
< element name =" license " >
< field name =" bin " > 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 </ field >
</ element >
</ metadata >